Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion
| Tracking Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | April 25, 2007 | ||||||||||||
| Last Updated Date | March 28, 2012 | ||||||||||||
| Start Date ICMJE | February 2007 | ||||||||||||
| Primary Completion Date | November 2009 (final data collection date for primary outcome measure) | ||||||||||||
| Current Primary Outcome Measures ICMJE |
Complete abortion without recourse to surgical intervention. [ Time Frame: follow up visit 7 days after initial treatment ] [ Designated as safety issue: No ] | ||||||||||||
| Original Primary Outcome Measures ICMJE |
Complete abortion without recourse to surgical intervention. | ||||||||||||
| Change History | Complete list of historical versions of study NCT00466999 on ClinicalTrials.gov Archive Site | ||||||||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||||||
| Descriptive Information | |||||||||||||
| Brief Title ICMJE | Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion | ||||||||||||
| Official Title ICMJE | Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion | ||||||||||||
| Brief Summary | In this study, we will compare the safety and efficacy of 400 mcg sublingually administered misoprostol alone to standard surgical care for the treatment of incomplete abortion. This study will provide important data on the role of misoprostol in health services offering an array of treatments for incomplete abortion. Women could significantly benefit from a non-invasive treatment option for incomplete abortion. While safe surgical services are becoming more widespread, there is still a serious risk of complications from these procedures. Especially in developing countries, infection, hemorrhage and uterine damage are still too common. Medical treatment of incomplete abortion using misoprostol would be a tremendous step to reducing morbidity and mortality due to abortion complications. |
||||||||||||
| Detailed Description | Not Provided | ||||||||||||
| Study Type ICMJE | Interventional | ||||||||||||
| Study Phase | Not Provided | ||||||||||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
||||||||||||
| Condition ICMJE | Incomplete Abortion | ||||||||||||
| Intervention ICMJE |
|
||||||||||||
| Study Arm (s) |
|
||||||||||||
| Publications * |
|
||||||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||
| Recruitment Information | |||||||||||||
| Recruitment Status ICMJE | Completed | ||||||||||||
| Enrollment ICMJE | 1000 | ||||||||||||
| Completion Date | November 2009 | ||||||||||||
| Primary Completion Date | November 2009 (final data collection date for primary outcome measure) | ||||||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||||||
| Gender | Female | ||||||||||||
| Ages | Not Provided | ||||||||||||
| Accepts Healthy Volunteers | Yes | ||||||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||||||
| Location Countries ICMJE | Burkina Faso, Egypt, Mauritania, Niger, Senegal | ||||||||||||
| Administrative Information | |||||||||||||
| NCT Number ICMJE | NCT00466999 | ||||||||||||
| Other Study ID Numbers ICMJE | 2.2.2 | ||||||||||||
| Has Data Monitoring Committee | No | ||||||||||||
| Responsible Party | Gynuity Health Projects | ||||||||||||
| Study Sponsor ICMJE | Gynuity Health Projects | ||||||||||||
| Collaborators ICMJE | Not Provided | ||||||||||||
| Investigators ICMJE |
|
||||||||||||
| Information Provided By | Gynuity Health Projects | ||||||||||||
| Verification Date | March 2012 | ||||||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||||||